Phase I study of Adva 27a for use in patients with multidrug-resistant breast cancer
Phase of Trial: Phase I
Latest Information Update: 25 Feb 2015
At a glance
- Drugs Adva 27a (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- Sponsors Sunshine Biopharma
- 25 Feb 2015 This trial is still in the planning stage, according to a Sunshine Biopharma media release.
- 13 Sep 2012 This trial is still in the planning stages, according to a Sunshine Biopharma media release.
- 14 Oct 2010 New trial record